Kamar N - Search Results

1

Low serum neutralization of Omicron variants a month after AZD7442 prophylaxis initiation.

de Lamballerie X, Martin-Blondel G, Dupont A, Izopet J, Mentré F, Kamar N, Autran B, Paintaud G, Caillard S, le Bourgeois A, Richez C, Couzi L, Xhaard A, Marjanovic Z, Avouac J, Jacquet C, Anglicheau D, Cheminant M, Yazdanpanah Y, Guyen SN, Terrier B, Gottenberg JE, Besson C, Letrou S, Kali S, Angoulvant D, Sanchez VP, Tardivon C, Blancho G, Lévy V. de Lamballerie X, et al. Among authors: kamar n. J Infect. 2023 Jan;86(1):66-117. doi: 10.1016/j.jinf.2022.10.006. Epub 2022 Oct 8. J Infect. 2023. PMID: 36216187 Free PMC article. No abstract available.

2

Evolution of hepatitis C virus quasispecies in renal transplant patients with de novo glomerulonephritis.

Kamar N, Rostaing L, Boulestin A, Sandres K, Dubois M, Ribes D, Modesto A, Durand D, Izopet J. Kamar N, et al. J Med Virol. 2003 Apr;69(4):482-8. doi: 10.1002/jmv.10335. J Med Virol. 2003. PMID: 12601755

3

[Is there a place for ribavirin in the treatment for renal transplant patients infected by hepatitis C virus?].

Kamar N, Sandres-Saune K, Selves J, Durand D, Izopet J, Rostaing L. Kamar N, et al. Nephrologie. 2003;24(2):89-94. Nephrologie. 2003. PMID: 12723514 French.

4

[Hepatitis C infection among patients receiving hemodialysis].

Kamar N, Izopet J, Rostaing L. Kamar N, et al. Nephrologie. 2003;24(3):133-41. Nephrologie. 2003. PMID: 12814060 Review. French.

5

Long-term ribavirin therapy in hepatitis C virus-positive renal transplant patients: effects on renal function and liver histology.

Kamar N, Sandres-Saune K, Selves J, Ribes D, Cointault O, Durand D, Izopet J, Rostaing L. Kamar N, et al. Am J Kidney Dis. 2003 Jul;42(1):184-92. doi: 10.1016/s0272-6386(03)00422-0. Am J Kidney Dis. 2003. PMID: 12830471 Clinical Trial.

6

Evidence that clearance of hepatitis C virus RNA after alpha-interferon therapy in dialysis patients is sustained after renal transplantation.

Kamar N, Toupance O, Buchler M, Sandres-Saune K, Izopet J, Durand D, Rostaing L. Kamar N, et al. J Am Soc Nephrol. 2003 Aug;14(8):2092-8. doi: 10.1097/01.asn.0000079613.81511.3c. J Am Soc Nephrol. 2003. PMID: 12874463

7

Ribavirin pharmacokinetics in renal and liver transplant patients: evidence that it depends on renal function.

Kamar N, Chatelut E, Manolis E, Lafont T, Izopet J, Rostaing L. Kamar N, et al. Am J Kidney Dis. 2004 Jan;43(1):140-6. doi: 10.1053/j.ajkd.2003.09.019. Am J Kidney Dis. 2004. PMID: 14712437

8

[Hepatitis C virus infection in renal-transplant patients].

Kamar N, Izopet J, Ribes D, Rostaing L. Kamar N, et al. Nephrologie. 2004;25(1):9-15. Nephrologie. 2004. PMID: 15022868 Review. French.

9

Amantadine therapy in renal transplant patients with hepatitis C virus infection.

Kamar N, Rostaing L, Sandres-Saune K, Ribes D, Durand D, Izopet J. Kamar N, et al. J Clin Virol. 2004 May;30(1):110-4. doi: 10.1016/j.jcv.2003.10.001. J Clin Virol. 2004. PMID: 15072764 Clinical Trial.

10

Acute hepatitis and renal function impairment related to infection by hepatitis E virus in a renal allograft recipient.

Kamar N, Mansuy JM, Esposito L, Legrand-Abravanel F, Peron JM, Durand D, Rostaing L, Izopet J. Kamar N, et al. Am J Kidney Dis. 2005 Jan;45(1):193-6. doi: 10.1053/j.ajkd.2004.09.006. Am J Kidney Dis. 2005. PMID: 15696460

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

724 results

Search Page